Top Midday Decliners

MT Newswires Live06-05

Broadcom's (AVGO) decision not to upgrade its 2027 artificial intelligence guidance apparently disappointed investors, especially as the chip designer reported strong semiconductor demand, UBS Securities said in a client note sent Thursday.

Shares dropped 13%, with intraday trading volume rising to more than 62.1 million from the stock's daily average of about 24.4 million.

ADC Therapeutics (ADCT) shares sank 55% amid heavy trading after RBC downgraded the company's stock rating and lowered its price target to $2 from $6, following new late-stage trial data for the company's lymphoma therapy Zynlonta.

More than 9.1 million shares of the company traded intraday compared with a daily average of about 990,000.

Xos (XOS) has announced a registered direct offering of about 1.09 million common shares at $5.50 per share, for gross proceeds of about $6 million, the company said Thursday.

Shares sank 26% following an increase in intraday trading volume to over 10.8 million from a daily average of about 2.24 million.

Price: 417.61, Change: -61.62, Percent Change: -12.86

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment